BioSig Technologies, Inc. STEX Cash Provided by (Used in) Operating Activity, Including Discontinued Operation
Cash Provided by (Used in) Operating Activity, Including Discontinued Operation at other companies
Other financials
Where this comes from
Reported directly by BioSig Technologies, Inc. in its filing.
Tagged under the XBRL concept us-gaap:NetCashProvidedByUsedInOperatingActivities.
The official record: BioSig Technologies, Inc.’s 10-Q, filed May 14, 2026, on SEC EDGAR. View the filing →
Ask your AI about BioSig Technologies, Inc.'s cash provided by (used in) operating activity, including discontinued operation.
Connect your AI assistant and compare it to peers, right in your chat.
Connect your AI
Claude
Questions, answered.
- What is BioSig Technologies, Inc.'s cash provided by (used in) operating activity, including discontinued operation?
- BioSig Technologies, Inc. (STEX) reported cash provided by (used in) operating activity, including discontinued operation of -$10.18M in Q1 2026.
- How has BioSig Technologies, Inc.'s cash provided by (used in) operating activity, including discontinued operation changed year-over-year?
- BioSig Technologies, Inc.'s cash provided by (used in) operating activity, including discontinued operation decreased by 812.9% year-over-year, from -$1.12M to -$10.18M.
- What is the long-term trend for BioSig Technologies, Inc.'s cash provided by (used in) operating activity, including discontinued operation?
- Over 4 years (2021 to 2025), BioSig Technologies, Inc.'s cash provided by (used in) operating activity, including discontinued operation has grown at a -20.7% compound annual growth rate (CAGR), from -$26.4M to -$10.44M.
- What does cash provided by (used in) operating activity, including discontinued operation mean?
- Measures the cash generated from the company's core business operations, excluding financing and investing activities. It reflects the ability of the company to convert revenue into actual cash flow after accounting for changes in working capital.